INTRODUCTION
Erythritol has been used since 1990 in Japan as a component of candies, sugar substitutes, chocolates, Erythritol is a four-carbon sugar alcohol (polyol) that soft drinks, chewing gum, jellies, jams, and yogurt has a sweetness 60 to 80% that of sucrose (Sugita and (Mitsubishi and Nikken, 1996) . These uses amount to Yamazaki, 1988; Goossens and Röper, 1994) and is ina per capita consumption in Japan of approximately tended for use in food principally as a low-calorie sweet-46 mg erythritol/day (Mitsubishi and Nikken, 1996) ener. Its structure is shown in Fig. 1 . It is produced or approximately 0.7 mg/kg body wt/day for a 60-kg from wheat or corn starch by enzymatic hydrolysis individual. yielding glucose which is fermented by safe and suitIn the United States, erythritol is intended for use able food-grade osmophilic yeasts, such as Moniliella as a flavor enhancer, formulation aid, humectant, nupollinis (Goossens and Röper, 1994) or Trichosporo-tritive sweetener, stabilizer and thickener, sequesnoides spp. Once erythritol is separated from the fer-trant, and texturizer at maximum levels of 100% in mentation broth, it is purified by processes typical for sugar substitutes; 50% in hard candies; 40% in soft carbohydrate sweeteners and sugar alcohols (i.e., car-candies (mints and chocolates only); 1.5% in reducedbon filtration and resin treatment). The final crystal-and low-calorie beverages; 60% in fat-based cream for line product is more than 99% pure. use in cookies, cakes, and pastries; 7% in dietetic cookErythritol occurs widely in nature and has been ies and wafers; and 60% in chewing gum. found to occur naturally in several foods including Erythritol is intended to be used in the same manner wine, sake, beer, mushroom, watermelon, pear, grape, as existing polyol food ingredients. Because erythritol and soy sauce at levels up to 0.13% (w/v) (Onishi and in most applications will substitute for these polyols, Saito, 1959 Saito, , 1960 Yoshida et al., 1984; Shindou et al., its actual per capita intake will not exceed that re-1988 , 1989 Sponholz and Dittrich, 1985; Sponholz et ported for total polyols. al., 1986; Dubernet et al., 1974) . Per capita consumpEstimating total polyol intake from dietary surveys tion of erythritol in the United States from its natural of motivated groups, such as persons with diabetes, led occurrence in foods (mostly cheese and wine) has been to average daily intakes of 4 g polyol/day based on a 7-estimated to be 80 mg/person/day or approximately 1.3 day UK survey (Ministry of Agriculture, Fisheries and mg/kg body wt/day (Modderman, 1996a,b) . Food, 1990 ) and 5 g polyol/day based on a 2-day Finnish Evidence indicates that erythritol exists endoge-survey (Virtanen et al., 1988) . Considering the techninously in the tissue and body fluids of humans and cal properties and expected market of erythritol, proanimals (Spencer, 1967; Horning et al., 1974;  Oku and jected at no more than 20% of total polyols, its actual Noda, 1990a,b; Goossens and Röper, 1994; Noda et al., long-term intake is reasonably expected to be approxi-1994). It has been identified in human plasma at levels mately 1 g erythritol/day (17 mg/kg body wt/day) and of approximately 1.2 mg/liter (Niwa et al., 1993) as well 4 g erythritol/day (67 mg/kg body wt/day) for mean and as in fetal blood of animals (Britton, 1967; Roberts et 90th percentile users, respectively. al., 1976) . Erythritol also occurs normally in human Based on a recent 3-day food intake survey conducted urine (Goossens and Röper, 1994) . Urinary concentra-by the U.S. Department of Agriculture and on an indetions have been reported to range from 10 to 100 mg/ pendent chewing gum survey, and assuming that liter (Pitkä nen and Pitkä nen, 1964) or 42 to 65 mg/g erythritol will be used in all intended applications with no other polyols, a ''maximum possible'' erythritol increatinine (Pfaffenberger et al., 1976) .
to D-erythrulose-1-phosphate via a-glycerophosphate dehydrogenase (Chü and Ballou, 1961; Maret and Ault, 1988) .
Following absorption, erythritol is rapidly distributed throughout the body and has been reported to occur in hepatocytes, pancreatic cells, and vascular smooth muscle cells (Johansson, 1969; Jonsson, 1971;  FIG. 1. Chemical structure of erythritol.
de Pont et al., 1978; Dewhurst et al., 1978; Lake et al., 1985; Alpini et al., 1986) . Bile concentrations of erythritol are proportional to plasma erythritol concentrations (Westendorf and Czok, 1983) . Erythritol also take was also estimated (Fleming, 1995) . Erythritol inhas been reported to transfer across the human platakes by ''eaters only'' of the total U.S. population for centa (Schneider et al., 1985; Jansson et al., 1993) and all food categories, excluding chewing gum, were estihas been reported to pass slowly from the plasma into mated to be 7 g/day (115 mg/kg body wt/day) and 16 the brain and cerebrospinal fluid of sheep (Dziegielewg/day (264 mg/kg body wt/day) for mean and 90th perska et al., 1979) . centile users, respectively. Erythritol intakes by eaters
In humans, plasma erythritol levels were reported only of the total U.S. population for chewing gum use to reach a maximum of about 3 to 25 mmol/liter (366 only were estimated to be 4 g/day (67 mg/kg body wt/ to 3050 mg/liter) within 30 to 120 min following ingesday) and 8 g/day (133 mg/kg body wt/day) for mean and tion of 0.3 to 1 g erythritol/kg body wt (Noda et al., 90th percentile users, respectively. When considering 1994; Bornet et al., 1996a,b) . Absorption of erythritol these data together with the assumption that erythritol appears to be protracted when taken with food rather will be used in foods at levels no greater than 20% than in aqueous solution on an empty stomach, possiof total polyols, as previously discussed, the resulting bly due to delayed gastric emptying. intake values are very similar to those derived from Absorbed erythritol is rapidly excreted unchanged in the UK and Finnish dietary surveys.
the urine (Oku and Noda, 1990a; Bornet et al., 1992 , Based on the available survey data, it can be con1996a,b; Hiele et al., 1993; Noda et al., 1994;  Tetzloff et cluded that the 90th percentile user of erythritol would al., 1996). As indicated earlier, the unabsorbed fraction be expected to have a daily erythritol intake of no more may undergo colonic fermentation or be excreted in the than 4 g/day (67 mg/kg body wt) with a more likely feces. In dogs, less than 2% of ingested erythritol is intake estimate of approximately 1 g/day (17 mg/kg excreted unchanged via the feces (Dean et al., 1996 ; body wt/day) for mean users. Noda et al., 1996) and in rats, similar results have been reported (Oku and Noda, 1990a,b; Noda and Oku, 1990 ; Noda et al., 1996; Van Ommen et al., 1996) . The biliary excretion of erythritol In humans, most (60 to 90%) ingested erythritol is rapidly absorbed via the small intestine (Höber and has been estimated at 1% using bile-cannulated dogs (Lewis et al., 1982) . Höber 1937; Lauwers et al., 1985; Winne et al., 1985 Winne et al., , 1987 Oku and Noda, 1990a; Bornet et al., 1992 Bornet et al., , 1996a Hiele et al., 1993; Noda et al., 1994; Tetzloff TOXICOLOGICAL STUDIES et al., 1996) . Studies with rodents and dogs have shown similar absorption rates (Noda and Oku, 1990; Numerous toxicological studies have been conducted and Noda, 1990a,b; Dean et al., 1996; Lina et al., 1996 ; to evaluate the safety of erythritol. The following is a Noda et al., 1996; Van Ommen et al. , summary of the pivotal published studies demonstra-1996). Unabsorbed erythritol undergoes microbial fer-ting the safety of erythritol for use in foods. mentation in the colon to volatile fatty acids (Noda and Acute Studies Oku, 1990 Oku, , 1992 .
BIOCHEMICAL STUDIES

Lina
In vitro studies and studies in rodents (Beck et al., No effects in rats, other than diuresis, have been 1938; McCorkindale and Edson, 1954; Batt et al., 1960;  reported following single gavage doses as high as 18 g Oku, 1990, 1992; Noda et al., 1996 ; Van Om-erythritol/kg body wt (Beck et al., 1936 (Beck et al., , 1938 (Beck et al., ). men et al., 1996 and humans (Bornet et al., 1992; Hiele et al., 1993; Noda et al., 1994) demonstrate that eryth-Subchronic Studies ritol is not metabolized systemically; however, it may be involved to a minor extent in some reversible metaSeveral published subchronic studies in experimental animals have demonstrated the safety of erythritol bolic reactions such as dehydrogenation to D-or Lerythrulose by NDA-dependent cytoplasmatic polyol for food use (Oku and Noda, 1990a; Dean et al., 1996; . The key dehydrogenase or phosphorylation by glycerol kinase to erythritol-1-phosphate followed by dehydrogenation subchronic studies are summarized in Table 1 and most of these studies are discussed in detail elsewhere in ad libitum fed 20% dose group. Although dose-related increases in cecal weight and absolute and relative kidthis journal issue. Rats fed 5 or 10% erythritol in the diet (approximately 5 or 10 g/kg body wt/day) for 28 ney weights were reported in rats and mice, these were not accompanied by histopathological changes. days showed no effects on food consumption, weight gain, organ weights, hematological parameters, or orIn further support of the safety of erythritol, a 1-year dietary study in dogs showed no adverse effects when gans following histological examination. However, polydipsia, diuresis, slight increases in cecal weight, erythritol was fed at 0, 2, 5, or 10% in the diet (approximately 0, 0.7, 1.8, or 3.5 g/kg body wt/day) (Dean et al., and an initial transient diarrhea, mostly in the 10% group, were reported (Oku and Noda, 1990b; . As with the shorter term rodent studies, there were no clinically relevant changes in hematological . These effects are known to occur commonly in rodents fed polyols (Bä r, 1985) . In a study or clinicochemical parameters and no histopathological abnormalities. Urinary enzymes remained within norin which rats and mice were fed erythritol for 13 weeks at dietary concentrations of 0, 5, 10, or 20% (approxi-mal limits in the dog study. mately 0, 3, 6, or 12 and 0, 11, 23, or 45 g erythritol/ kg body wt/day for rats and mice, respectively), no signs Chronic Studies of overt toxicity were evident nor were there any effects on hematological and clinicochemical parameters (Til The results of a chronic rat study [described in detail elsewhere in this journal issue (Lina et al., 1996) ] have et al., 1996) . One rat group also was given a restricted diet (food access for 6 hr/day) containing 20% erythri-shown that doses of erythritol up to 5.4 g/kg body wt/ day for 2 years showed no evidence of toxicity and were tol. Transient diarrhea similar to the 28-day studies was observed in some rats receiving 20% erythritol. In not carcinogenic. Groups of male and female Wistar rats were fed 0, 2, 5, or 10% erythritol in the diet (apboth species, urine output increased with increasing erythritol dose particularly at the two highest dose lev-proximately 0, 0.86, 2.2, or 4.6 and 0, 1.0, 2.6, or 5.4 g/kg body wt/day for male and female rats, respectively) els (i.e., 10 and 20%) indicating a diuretic effect of erythritol. In mice, the urinary excretion of creatinine-for 105 to 107 weeks. A positive control group was fed 10% mannitol in the diet. There were no effects on the normalized protein, g-glutamyl transferase (GGT), and electrolytes was significantly increased in the high-general condition or behavior of treated animals. Urine volume was significantly increased in the 10% erythridose group, whereas urinary N-acetylglucosaminidase (NAG) was not affected. In the 10% dose group, urinary tol group except at Week 102. This was accompanied by a significant increase in NAG. There also were slight protein also was increased and GGT activity showed slight, but significant, increases in males only. GGT increases in urinary excretion of low-molecular-weight protein, total protein, and electrolytes at the 10% erythactivity also was increased in female mice fed 5% erythritol but not in the 10% dose group. Rats showed no ritol level. The urinary concentration of the renal brush-border enzyme GGT was significantly increased treatment-related changes in these urinary parameters, except that, in the 20% dose groups, urinary cal-in the first year of the study (Week 50) in the 5 and 10% erythritol groups. Increased GGT continued to Week 78 cium and NAG levels were significantly increased. Urinary potassium was significantly increased only in the in the 10% group only but was similar to controls at Week 102 indicating that this effect was not progres-ritol/kg body wt/day during Days 6 to 18 of gestation (Shimizu et al., 1996) . Although transient maternal efsive. Food and water consumption also were increased, but body weights were significantly reduced only in the fects (i.e., polyuria, auricular edema, and bradypragia), likely related to osmotic load, were observed at the high-dose animals. As in the other published dietary studies, cecal weights (full and empty) were signifi-highest dose tested, no effects on fetal development were found. There were no differences in body weight cantly increased in the high-dose rats and occasionally in the mid-dose rats. Although relative kidney weights or food consumption of treated maternal animals when compared with control animals. No abnormalities realso tended to be increased in rats in the 10% erythritol group (relative kidney weights were significantly in-lated to treatment were found in the histopathological examination of the maternal animals. Skeletal and viscreased in males at Weeks 52 and 78, but not Week 104 and in females at Week 104), histopathological ex-ceral examinations of the fetuses revealed no treatment-related effects. This study is discussed in detail amination of all organs was unremarkable except for a statistically significant increase in the incidence of elsewhere in this journal issue. pelvic nephrocalcinosis in females of all erythritol groups and in both male and female rats in the 10% Mutagenicity mannitol group.
Erythritol at concentrations of up to 30 mg/plate has shown no mutagenic activity when tested in five SalmoReproductive Toxicity Studies nella typhimurium strains (TA1535, TA1537, TA1538, To further examine the safety of erythritol in foods, TA98, and TA100) using the Ames assay with or witha two-generation reproduction study was conducted us-out metabolic activation with liver S9 from Arocloring rats. This study (Waalkens-Berendsen et al., 1996) induced rats (Blijleven, 1990) . Similar results have is described in detail elsewhere in this journal issue. been reported in another study using S. typhimurium Groups of 24 male and 24 female rats were fed erythri-strains TA98, TA100, TA1535, and TA1537 as well as tol at dietary concentrations of 0, 2.5, 5, or 10% (approx-in Escherichia coli strain WP2 uvrA (Kawamura et al., imately 0, 1.4 to 3.8, 2.8 to 7.5, or 6.5 to 16 g/kg body 1996). In the same study, erythritol at concentrations wt/day, respectively, depending on the stage of the of up to 10 mM also tested negative in chromosome pregnancy) for approximately 10 weeks prior to mating aberration tests using the Chinese hamster fibroblast and during gestation. Twenty-four offspring of each sex cell line CHL/IU. These uniformly negative results inand dose group formed the second generation and were dicate that erythritol is not mutagenic. treated similarly as the parental generation. For each generation, one litter was reared to 21 days. Erythritol
CLINICAL STUDIES
did not affect the reproductive performance or fertility of the parental rats. Also, there were no effects on the In addition to the numerous safety studies conducted development of the offspring. As with all the published in animals, several clinical studies with erythritol have animal feeding studies on erythritol, histopathological been published (Bornet et al., 1996a,b; Ishikawa et al., examination revealed no abnormalities. 1996; Oku and Okazaki, 1996; Tetzloff et al., 1996) . Four of these studies (Bornet et al., 1996a,b; Ishikawa Teratology Studies et al., 1996; Tetzloff et al., 1996) are discussed in detail elsewhere in this journal issue. In most of the studies, Dietary administration of high concentrations of erythritol (i.e., up to 10% of the diet) to pregnant rats erythritol was administered in either an aqueous solution or as part of a meal to healthy male and female did not result in any abnormal effects on the fetus (Smits-van Prooije et al., 1996) . Groups of 32 pregnant subjects for periods of 1 to 14 days. Overall, single or repeated oral doses of about 1 g erythritol/kg body wt/ Wistar rats were fed 0, 2.5, 5, or 10% erythritol in the diet (approximately 0, 1.7, 3.3, or 6.6 g erythritol/kg day caused no adverse effects in humans. In these studies, urine output, water intake, hematology, and gasbody wt/day) during Gestation Days 0 to 21. No mortality occurred and weight gain during gestation, food con-trointestinal side-effects were examined. In two of the studies, urinary enzymes also were analyzed (Bornet et sumption, food efficiency, and reproductive performance were similar in all groups with the exception of al Tetzloff et al., 1996) . No clinically significant effects on these parameters were evident in the studies, reduced weight gain in the animals of the high-dose group during the second week of gestation. Examina-although, as expected on the basis of the diuretic effect of erythritol, some increases in urinary volume with tion of the fetuses for external, visceral, and skeletal abnormalities revealed no fetotoxic, embryotoxic, or te-increased electrolyte excretion and water intake were observed, as were slight elevations of urinary NAG, ratogenic effects. Even when administered intravenously to rabbits at similar doses, no teratogenic poten-albumin, and b 2 -m-globulin. The enzyme and protein values were within the normal physiological range tial has been reported (Shimizu et al., 1996) . Rabbits were injected intravenously with 1.0, 2.2, or 5.0 g eryth- (Tetzloff et al., 1996) . Although urinary GGT also was analyzed in two of the clinical studies (Bornet et al., dorf et al., 1994) as well as electrolytes (Guyton, 1987) .
In dogs given erythritol, urinary enzymes remained 1996b; Tetzloff et al., 1996) , it has been shown that GGT is unstable under the storage conditions used and within normal limits. In all of the animal-feeding studies conducted, no evidence of kidney damage was obthat erythritol enhances the stability of the enzyme (Loeb and Das, 1996) making any comparison with con-served histopathologically.
In the 13-week study , a statistically trols uninterpretable. For these reasons, the GGT data were not further evaluated.
significant increase in the relative kidney weights was reported at the highest dose in male rats and mice of Clinical studies also have been conducted in persons with diabetes. Five subjects (three males and two fe-both sexes. Likewise in the 2-year rat study (Lina et al., 1996) , the relative kidney weights were significantly males) given a single 20-g dose of erythritol in aqueous solution had blood and urine samples taken at various increased at the end of the study in high-dose females and at the interim necropsy (Week 78) in high-dose intervals prior to and after erythritol ingestion (Ishikawa et al., 1996) . Blood samples were analyzed for males. In both studies, these increases were not accompanied by histopathological changes, except for pelvic glucose, insulin, free fatty acids, 3-hydroxybutyric acid, and erythritol. Urine samples were analyzed for ery-nephrocalcinosis in the female rats fed erythritol for 2 years. Pelvic nephrocalcinosis also was observed in rats thritol. Consumption of 20 g of erythritol did not affect any of the parameters tested. Similarly, in the same administered 10% mannitol over 2 years. This histopathological finding is a common occurrence in rodents study, when 20 g erythritol was administered daily for 14 days, no significant effects on the above and follow-fed polyols or slowly digestible carbohydrates (Gongwer et al., 1978; Sinkeldam et al., 1983 Sinkeldam et al., , 1992 Bä r, 1984 , ing parameters were observed. In this longer term study, additional analyses were conducted including 1985 Roe and Bä r, 1985; FASEB, 1986; Woutersen, 1987; Conz and Fumero, 1989; Dills, 1989 ; Conz measurement of body weight, fasting blood sugar, hemoglobin Alc, blood urea nitrogen, creatinine, b 2 -m-and Maraschin, 1992).
The large body of published data supports the concluglobulin, and urinary proteins.
sion that the intake of erythritol would not be expected to cause adverse effects in humans under the condi-
DISCUSSION
tions of its intended use in food. The available metabolic studies demonstrate that erythritol is readily abIn the published literature, there is a considerable body of evidence supporting the safety of erythritol sorbed, not systemically metabolized and rapidly excreted unchanged in the urine. Moreover, erythritol for its use as a sweetener in foods. Erythritol is well absorbed (Ç60 to 90%), with only small amounts occurs endogenously and naturally in the diet. Both animal toxicological studies and clinical studies have available to undergo colonic fermentation, and, therefore, limited gastrointestinal side-effects occur. consistently demonstrated the safety of erythritol even when consumed at levels well in excess of the expected In the clinical studies, no significant gastrointestinal effects were found at doses up to 1000 mg/kg body daily intake. Based on the food safety data available in the published literature, the authors conclude that wt/day. These doses far exceed the estimated daily intake of approximately 4200 mg/day (approximately other qualified food safety experts would agree that erythritol is generally recognized as safe (GRAS) under 70 mg/kg body wt/day for a 60-kg individual). These findings are well supported by toxicological studies the conditions of its intended use in food. in which experimental animals received high oral doses of erythritol (i.e., up to 45 g/kg body wt/day) REFERENCES for 13 weeks without any significant gastrointestinal effects.
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